A carregar...
CAR-T cells and combination therapies: what’s next in the immunotherapy revolution?
Cancer immunotherapies are dramatically reshaping the clinical management of oncologic patients. For many of these therapies, the guidelines for administration, monitoring, and management of associated toxicities are still being established. This is especially relevant for adoptively transferred, ge...
Na minha lista:
| Publicado no: | Pharmacol Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828987/ https://ncbi.nlm.nih.gov/pubmed/29203440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.phrs.2017.11.035 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|